Article Versions Notes

Arosio G, Sharma GG, Villa M, Mauri M, Crespiatico I, Fontana D, Manfroni C, Mastini C, Zappa M, Magistroni V, et al. Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers. 2021; 13(17):4422. https://doi.org/10.3390/cancers13174422

Arosio, Giulia, Geeta G. Sharma, Matteo Villa, Mario Mauri, Ilaria Crespiatico, Diletta Fontana, Chiara Manfroni, Cristina Mastini, Marina Zappa, Vera Magistroni, and et al. 2021. "Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma" Cancers 13, no. 17: 4422. https://doi.org/10.3390/cancers13174422

Arosio, G., Sharma, G. G., Villa, M., Mauri, M., Crespiatico, I., Fontana, D., Manfroni, C., Mastini, C., Zappa, M., Magistroni, V., Ceccon, M., Redaelli, S., Massimino, L., Garbin, A., Lovisa, F., Mussolin, L., Piazza, R., Gambacorti-Passerini, C., & Mologni, L. (2021). Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers, 13(17), 4422. https://doi.org/10.3390/cancers13174422